Treatment with an anti-VEGFR-2 mAb of immunodeficient mice transplanted with HL-60 cells inhibited leukemia growth; however, the in vivo activity of the anti-VEGFR-1 mAb was not tested [277]. This evidence concerns the gene KDR and leukemia.